HCID 58691191, compound → HCID 10051156, compound
Reaction equation
[NH2:1][C@H:2]1[CH2:8][CH:7]=[CH:6][C@@H:5]([C:9]2[CH:14]=[CH:13][CH:12]=[CH:11][CH:10]=2)[N:4]([CH2:15][CH2:16][O:17][CH3:18])[C:3]1=[O:19].[OH:20][C@@H:21]([CH2:33][CH:34]([CH3:36])[CH3:35])[C:22]([NH:24][C@H:25]([C:30](O)=[O:31])[CH2:26][CH:27]([CH3:29])[CH3:28])=[O:23]>>[OH:20][C@@H:21]([CH2:33][CH:34]([CH3:36])[CH3:35])[C:22]([NH:24][C@H:25]([C:30]([NH:1][C@H:2]1[CH2:8][CH:7]=[CH:6][C@@H:5]([C:9]2[CH:10]=[CH:11][CH:12]=[CH:13][CH:14]=2)[N:4]([CH2:15][CH2:16][O:17][CH3:18])[C:3]1=[O:19])=[O:31])[CH2:26][CH:27]([CH3:28])[CH3:29])=[O:23]Participants
3
Procedure
Utilizing (3S,7S)-3-amino-1-(2-methoxyethyl)-7-phenyl-1,3,4,7-tetrahydro-2H-azepin-2-one (6d) and N-[(2S)-2-hydroxy-4-methylpentanoyl]-L-leucine (7b), the title compound was synthesized using the same procedure as that described for Example 6.
Sources & evidence
- ORD record
- ord-1c610d4d42ab430e9086874019956bb2
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07342007B2
Reaction notes
Loading…